ERJ Open Research

Papers
(The H4-Index of ERJ Open Research is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Increased loop gain and upper airway collapsibility among smoking patients with obstructive sleep apnoea219
Spirometry at different Latin American altitudes: a Global Lung Function Initiative project92
“Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts.” Michael R. Loebinger, Stefano Aliberti, Charles Haw81
Dysglycaemia among tuberculosis patients without known diabetes in a low-endemic setting62
Dual CFTR modulator therapy efficacy in the real world: lessons for the future61
Long-term incident severe outcomes in a prospective cohort of non-obese obstructive sleep apnoea patients free of comorbidities at inclusion55
Supplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturation53
Williams–Campbell syndrome case series and discordant twins44
Period and cohort effects: consequences on spirometric lung function in Norway during the 20th century37
Association of patient-reported outcome measures with lung function and mortality in fibrotic interstitial lung disease: a prospective cohort study36
Targeted DNase treatment of obstructive lung disease: a pilot randomised controlled trial35
Anodal transcranial direct current stimulation over the right primary somatosensory cortex increases cough reflex sensitivity: a pilot randomised controlled crossover trial35
Triple therapy in COPD: understanding the data32
Antitrypsin deficiency: still more to learn about the lung after 60 years31
Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial31
An observational study ofPseudomonas aeruginosain adult long-term ventilation31
Proteins associated with preserved ratio impaired spirometry30
The noninvasive ventilation outcomes score in patients requiring NIV for COPD exacerbation without prior evidence of airflow obstruction30
High-frequency percussive ventilation in acute respiratory failure30
Myostatin/Smad2/Smad3 pathway define a differential clinical phenotype in COPD-associated sarcopenia30
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience30
The NEuroCOUGH Chronic Cough Registry: a protocol for a pan-European observational study29
Prevalence and consequences of patient–ventilator interactions in a cohort of home-ventilated restrictive and neuromuscular patients: a multicentre study29
A survey of UK respiratory specialists’ opinion on the management of chronic cough29
Extracellular iron and the lung microbiome in smoking and COPD29
Serotype distribution and coverage by pneumococcal vaccines in hospitalized adults with pneumococcal pneumonia in Germany28
ERS International Congress 2022: highlights from the Basic and Translational Science Assembly27
0.60935711860657